Literature DB >> 16488130

Estrogen receptor alpha as a target for indole-3-carbinol.

Thomas T Y Wang1, Matthew J Milner, John A Milner, Young S Kim.   

Abstract

A wealth of preclinical evidence supports the antitumorigenic properties of indole-3-carbinol (I3C), which is a major bioactive food component in cruciferous vegetables. However, the underlying molecular mechanism(s) accounting for these effects remain unresolved. In the present study, estrogen receptor alpha (ER-alpha) was identified as a potential molecular target for I3C. Treating MCF-7 cells with 100 microM I3C reduced ER-alpha mRNA expression by approximately 60% compared to controls. This reduction in ER-alpha transcript levels was confirmed using real-time polymerase chain reaction. The I3C dimer, 3,3'-diindolylmethane (DIM), was considerably more effective in depressing ER-alpha mRNA in MCF-7 cells than the monomeric unit. The suppressive effects of 5 microM DIM on ER-alpha mRNA was comparable to that caused by 100 microM I3C. DIM is known to accumulate in the nucleus and is a preferred ligand for aryl hydrocarbon receptor (AhR) to I3C. The addition of other AhR ligands, alpha-naphthoflavone (alpha-NF, 10 microM) and luteolin (10 microM), to the culture media resulted in a similar suppression in ER-alpha mRNA levels to that caused by 5 microM DIM. Thus, it is likely that the binding of ligands to AhR inhibits nuclear ER-alpha transcript. The results from these experiments suggest that the antitumorigenic effects of I3C in MCF-7 human breast cancer cells may arise from its ability to reduce ER-alpha expression through the binding of its metabolite, DIM, to the nuclear AhR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16488130     DOI: 10.1016/j.jnutbio.2005.10.012

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  23 in total

1.  3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants.

Authors:  Massod Rahimi; Kai-Ling Huang; Careen K Tang
Journal:  Cancer Lett       Date:  2010-03-17       Impact factor: 8.679

2.  Natural indoles, indole-3-carbinol and 3,3'-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression.

Authors:  Philip B Busbee; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-05       Impact factor: 4.219

3.  (3-Chloroacetyl)-indole, a novel allosteric AKT inhibitor, suppresses colon cancer growth in vitro and in vivo.

Authors:  Dong Joon Kim; Kanamata Reddy; Myoung Ok Kim; Yan Li; Janos Nadas; Yong-Yeon Cho; Jong-Eun Kim; Jung-Hyun Shim; Nu Ry Song; Andria Carper; Ronald A Lubet; Ann M Bode; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-01

4.  Indole-3-carbinol inhibits MDA-MB-231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity.

Authors:  Christine T Brew; Ida Aronchik; Karena Kosco; Jasmine McCammon; Leonard F Bjeldanes; Gary L Firestone
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

Review 5.  Natural compounds as anticancer agents: Experimental evidence.

Authors:  Jiao Wang; Yang-Fu Jiang
Journal:  World J Exp Med       Date:  2012-06-20

6.  Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells.

Authors:  Joseph A Caruso; Rody Campana; Caimiao Wei; Chun-Hui Su; Amanda M Hanks; William G Bornmann; Khandan Keyomarsi
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 7.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

Review 8.  Minireview: modulation of hormone receptor signaling by dietary anticancer indoles.

Authors:  Gary L Firestone; Shyam N Sundar
Journal:  Mol Endocrinol       Date:  2009-10-16

9.  Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.

Authors:  Crystal N Marconett; Shyam N Sundar; Kevin M Poindexter; Theresa R Stueve; Leonard F Bjeldanes; Gary L Firestone
Journal:  Mol Biol Cell       Date:  2010-02-03       Impact factor: 4.138

10.  The role of estrogen receptor β in transplacental cancer prevention by indole-3-carbinol.

Authors:  Abby D Benninghoff; David E Williams
Journal:  Cancer Prev Res (Phila)       Date:  2013-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.